
|Videos|January 27, 2015
Surgery Preperation for Individuals With ITP
Advertisement
Episodes in this series

For High-Definition, Click
Keith McCrae, MD, notes that anesthesiologists and surgeons prefer to have platelet counts around 100,000 in preparation for surgery. There are at least 3 strategies to prepare a patient with idiopathic thrombocytopenic purpura (ITP) for surgery, explains Howard A. Liebman, MD. These include infusing platelets inter-operatively, administering intravenous immunoglobulin (IVIG), or using a thrombopoietin agonist, such as romiplostim, preceding surgical intervention. In emergency surgeries, the treatment of choice, says Leibman, remains IVIG with platelets and possibly corticosteroids.
Advertisement
Related to this article

The European Commission has approved epcoritamab plus lenalidomide and rituximab for relapsed or refractory follicular lymphoma.

The FDA approved Orca-T for use in matched donor HSCT with a myeloablative preparative regimen in hematological malignancies.

Both annamycin-containing arms produced numerically higher CR and CRc rates vs cytarabine alone in relapsed/refractory AML.

Romiplostim N01 supported platelet engraftment after unrelated umbilical cord blood transplantation with no serious TRAEs in hematologic malignancies.

The top 5 OncLive TV videos of the week cover insights in breast cancer, lymphoma, melanoma, prostate cancer, and ovarian cancer.

IV ST-001 nanoFenretinide produced a 28% response rate in heavily pretreated cutaneous T-cell lymphoma in a first-in-human phase 1a trial.
Advertisement
Advertisement
Trending on OncLive
1
Managing Long-Term Toxicities and Emerging Therapies in ALK-Positive NSCLC
2
TP53 Status and Time Toxicity Shape Sequencing Decisions in EGFR-Mutated NSCLC
3
Five Under 5: Top Oncology Videos for the Week of 6/28
4
Rusfertide Maintains Long-Term Thromboembolism Control in Phlebotomy-Dependent Polycythemia Vera
5












